Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 31)
24 October 2025
Merus Reports Positive Interim Data on Petosemtamab in Metastatic Colorectal Cancer
Petosemtamab shows promising response rates in 1L and 2L mCRC, with potential as a new standard of care.
24 October 2025
Johnson & Johnson's Icotrokinra Shows Promising Long-Term Results for Scalp and Genital Psoriasis
Icotrokinra achieves high skin clearance rates in difficult psoriasis areas over 52 weeks, maintaining safety and efficacy in both adults and adolescents.
24 October 2025
Eni Q3 and Nine-Month 2025 Results
Strong Q3 performance with increased cash generation, share buyback, and production growth. Strategic projects in LNG, biorefining, and CCUS advance, maintaining low leverage and stable dividends.
23 October 2025
BASF and ANDRITZ License Agreement for OASE Technology
OASE technology to capture 435,000 tons of CO2 annually in Aarhus waste-to-energy plant, pending Danish CCS fund approval.
23 October 2025
Arkema Advances Decarbonization at Lacq/Mourenx Site
Arkema's TREFLe Project cuts SO2 emissions by 40% and GHG by 10%, producing sulfuric acid for reuse and reducing water use, with €40M investment partly funded by France 2030 plan.
23 October 2025
RWE Begins 92 MW Onshore Wind Projects in Italy
RWE starts building two wind farms in Italy, totaling 92 MW, to power over 83,000 homes. Completion is set for late 2026.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
23 October 2025
NEXTCHEM Secures Engineering Contract with newcleo for Modular Nuclear Plant Design
NEXT-N to design a nuclear plant's conventional island, leveraging MAIRE's expertise, aiming for carbon-neutral chemistry with hydrogen and ammonia integration.
23 October 2025
INEOS Alerts Europe on Risk to Medicine Supply
European BDO production is threatened by cheap imports from China, risking jobs and medicine supply chains. Urgent EU action is needed to block unfair competition and protect local industry.
22 October 2025
Boehringer Ingelheim's JASCAYD® Approved in China for IPF Treatment
Nerandomilast, approved in China for IPF, showed significant lung function improvement in Phase III trials. It offers favorable tolerability and is also FDA-approved in the U.S.
22 October 2025
Equinor Q3 2025 Safety Report
A fatal accident occurred at Mongstad. Safety metrics improved, with reduced incident and injury frequencies. Focus on preventive measures and supplier collaboration continues.
22 October 2025
EU Report Highlights Growth in Sustainable Aviation Fuel
EASA's report shows increased SAF production in the EU, with biofuels dominating. A 2030 target of 6% SAF blending is on track, but synthetic fuels are still developing.
21 October 2025
Paques Biomaterials to establish PHA pilot from dairy by‑products at GETEC Park Emmen
In partnership with Looop, pilot will convert dairy by‑products (third validated sidestream after sewage sludge and paper process water) into PHA biomass and polymers, aiming for Q1 2026.
21 October 2025
Veolia to Operate Chile's First Desalination Plant in Valparaíso
Veolia wins a four-year contract to manage a desalination plant and aqueduct in Chile, focusing on renewable energy and local labor, with potential extensions until 2040.
21 October 2025
MOL Danube Refinery Fire Incident
A fire at the Danube Refinery's AV3 plant was contained. No injuries reported. Authorities monitor air quality. Hungarian fuel supply remains secure. Investigation and damage assessment ongoing.
21 October 2025
Port of Antwerp-Bruges: Mixed Results Amid Volatile Market
Container traffic stabilizes, bulk declines due to global uncertainty. US tariffs impact exports. European chemical sector faces challenges. RoRo and US trade show growth.
20 October 2025
Perpetual Next Appoints Gervais Green to Supervisory Board, Continues Partnership with ING Corporate Finance
Gervais Green joins to enhance governance and international growth. Collaboration with Fluor and ING supports biomethanol expansion and strategic partner admission.
20 October 2025
Johnson & Johnson's INLEXZO™ and Cetrelimab Show Promising Pre-Surgical Results in Bladder Cancer
Phase 2b study shows INLEXZO™ plus cetrelimab achieves significant pathologic response rates in muscle invasive bladder cancer patients ineligible for platinum-based chemotherapy.
20 October 2025
ORLEN Enhances Hydrogen Capabilities in Pomerania with Expert Support
Amber Hydrogen Valley receives expert advisory to optimize costs and guide it to final investment decision, aiming to build a full hydrogen value chain in Pomerania.
20 October 2025
WuXi Biologics Receives 2025 Global Customer Value Leadership Award from Frost & Sullivan
Recognized for innovation and operational excellence, the company supports 864 projects, achieving a 98% success rate in manufacturing and passing 44 global regulatory inspections.
20 October 2025
bp Announces Discovery in Namibia's Orange Basin
Volans-1X well in Orange Basin finds 26m of gas condensate reservoirs with high CGR. Third major 2025 discovery for Azule Energy partners. Further evaluation ongoing.
20 October 2025
Roche's Gazyva Approved by FDA for Lupus Nephritis Treatment
FDA approves Gazyva for lupus nephritis, showing superior results in trials, offering a new treatment option to prevent kidney disease progression.
19 October 2025
Johnson & Johnson's Subcutaneous Amivantamab Shows 45% Response Rate in Head and Neck Cancer
Subcutaneous amivantamab offers rapid, durable responses in head and neck cancer, with 82% tumor shrinkage and a median response duration of 7.2 months.
19 October 2025
Raludotatug Deruxtecan Shows 50.5% Response in Platinum-Resistant Ovarian Cancer, Reports Daiichi Sankyo and Merck
Raludotatug deruxtecan achieved a 50.5% response rate in phase 2 for platinum-resistant ovarian cancer, with a 5.6 mg/kg dose selected for phase 3.
18 October 2025
Genmab Reports Positive Phase 1/2 Trial Results for Rina-S in Advanced Endometrial Cancer
Rina-S shows 50% response rate in advanced endometrial cancer trial; FDA grants Breakthrough Therapy Designation.
18 October 2025
Merck and Eisai: KEYTRUDA and LENVIMA Show 5-Year Survival Benefit in Advanced Endometrial Carcinoma
KEYTRUDA and LENVIMA improve 5-year survival rates in advanced endometrial carcinoma compared to chemotherapy, with consistent results across patient subgroups.
18 October 2025
Merck's KEYTRUDA Plus Chemotherapy Reduces Disease Progression Risk in Platinum-Resistant Ovarian Cancer
KEYTRUDA with chemotherapy shows significant survival benefits in platinum-resistant ovarian cancer, leading to FDA priority review for expanded use.
17 October 2025
FDA Approves Novo Nordisk's Oral Semaglutide for CV Risk Reduction in High-Risk Type 2 Diabetes Adults
Oral semaglutide reduces major cardiovascular events in high-risk type 2 diabetes patients, showing a 14% risk reduction over 4 years, with consistent safety profile.
17 October 2025
Roche's Gazyva/Gazyvaro Gains EU CHMP Nod for Lupus Nephritis
CHMP backs Gazyva/Gazyvaro for lupus nephritis, showing superior renal response in trials. Awaiting European Commission decision.
17 October 2025
Mitsubishi Chemical's SoarnoL EVOH Resins Approved for Recyclability in Multilayer Films
RecyClass confirms multilayer films with up to 10% SoarnoL EVOH resins are recyclable with PE flexibles, supporting sustainable packaging and circular economy efforts.
16 October 2025
RIFT and Bureau Veritas Enhance Safety and Compliance
The partnership ensures Iron Fuel Technology meets high safety and compliance standards, supporting its transition from innovation to industrial-scale deployment.
← Previous
Next →
